METR-NK

· Anhui Provincial Cancer Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for METR-NK, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]

See pricing